Science behind Nutraceuticals

Clinical studies

1993 1994 1996 2000 2001 2002 2003 2004 2007 2008 2009 2010 2011 2012 2013 


Study with Omega-3 Product published in “Atherosclerosis”

ENA 
Equazen from Vifor reports on a new publication that concerns its product Equazen/eye qTMResearch to date has been dedicated to the field of neurodevelopmental disorders (NDD) and ADHD (1-4). The October issue of Atherosclerosis has now published a study on the effect of taking Equazen/eye qTM on risk factors for cardiovascular diseases (CVD) in obese adolescents (5). Atherosclerosis is a highly respected journal with an impact factor of 4.5 – which underlines the quality of this paper. more